NFE New beats Q4 earnings estimates despite continued losses but stock slides on demand concerns Braskem BAK Stock Key Resistance Trend Weakens 20260415 Is LiqTech International LIQT stock sensitive to the economy Q4 2025 EPS Misses Views MT Bank MTB Stock Trade Signals 155 20260415 RWAYI Runway Growth Finance Corp 725 Notes due 2031 reports 104 percent Q4 2025 EPS miss shares dip modestly after earnings WMK Weis Markets Inc rises 313 percent in daily trading following its Q3 2023 earnings release ARTL Artelo Biosciences Inc delivers 975 percent positive Q4 2025 EPS surprise but shares drop 864 percent today FCNCO First Citizens BancShares Inc 5625 Series C Preferred delivers narrow Q4 2025 earnings beat shares edge higher today DAC Danaos Corporation Q4 2025 earnings outperform estimates shares rise 218 percent on mild year over year revenue growth Reeds REED Cash Flow Analysis Q4 2025 Earnings Fall Short Lulus LVLU Stock Why It Matters Today 1467 20260420 Wyndham WH Stock Is It Forming a Reversal Flirts with Breakout 20260420 CONMED CNMD Stock Price Action Analysis Q4 2025 EPS Beats Forecasts Selective SIGIP Stock Forecast 2026 Buy Now Stalls 20260420 CRAI CRA Q4 2025 EPS falls modestly short of estimates while shares post small gains after results Wellgistics Health WGRX Stock Good Opportunity 556 20260420 DTST Data Storage Q4 2025 earnings trounce consensus EPS estimates shares post modest gains MTNB Matinas reports narrower Q4 2024 loss than analyst estimates shares rise modestly on positive investor sentiment Is Under UA stock in a strong position Under posts 537 EPS surprise beating loss estimates QNST QuinStreet tops first quarter 2026 earnings per share estimates stock gains 366 percent in todays trading Sow Good SOWG Sector Leadership Q3 2025 EPS Misses Views Lam LRCX Stock Is It Underpriced Lam beats EPS estimates by 62 on AI gear demand AC Spirits AGCC Stock Outlook Today Edges Lower 20260420 Avidia AVBC Stock Neutral Rating Steady Decline 20260416 Liberty LBTYA Stock Investment Intent Trend Weakens 20260415 NAMS NewAmsterdam Pharma Company NV Ordinary Shares reports widerthanexpected Q4 2025 losses stock dips 125 as revenue halves yearoveryear